CZ20011857A3 - Krystalická modifikace B kyseliny 8-kyano-1-cyklopropyl-7-(1S,6S-2,8-diazabicyklo-[4,3,0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarboxylové, způsob přípravy a její použití ve farmaceutických přípravcích - Google Patents

Krystalická modifikace B kyseliny 8-kyano-1-cyklopropyl-7-(1S,6S-2,8-diazabicyklo-[4,3,0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarboxylové, způsob přípravy a její použití ve farmaceutických přípravcích

Info

Publication number
CZ20011857A3
CZ20011857A3 CZ20011857A CZ20011857A CZ20011857A3 CZ 20011857 A3 CZ20011857 A3 CZ 20011857A3 CZ 20011857 A CZ20011857 A CZ 20011857A CZ 20011857 A CZ20011857 A CZ 20011857A CZ 20011857 A3 CZ20011857 A3 CZ 20011857A3
Authority
CZ
Czechia
Prior art keywords
nonan
diazabicyclo
cyclopropyl
dihydro
oxo
Prior art date
Application number
CZ20011857A
Other languages
English (en)
Other versions
CZ300012B6 (cs
Inventor
Thomas Himmler
Werner Hallenbach
Hubert Rast
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of CZ20011857A3 publication Critical patent/CZ20011857A3/cs
Publication of CZ300012B6 publication Critical patent/CZ300012B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CZ20011857A 1998-11-25 1999-11-15 Krystalická modifikace B kyseliny 8-kyano-1-cyklopropyl-7-(1S,6S-2,8-diazabicyklo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarboxylové,zpusob prípravy a její použití ve farmaceutickýchprípravcích CZ300012B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19854355A DE19854355A1 (de) 1998-11-25 1998-11-25 Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure

Publications (2)

Publication Number Publication Date
CZ20011857A3 true CZ20011857A3 (cs) 2001-09-12
CZ300012B6 CZ300012B6 (cs) 2009-01-14

Family

ID=7888959

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011857A CZ300012B6 (cs) 1998-11-25 1999-11-15 Krystalická modifikace B kyseliny 8-kyano-1-cyklopropyl-7-(1S,6S-2,8-diazabicyklo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarboxylové,zpusob prípravy a její použití ve farmaceutickýchprípravcích

Country Status (29)

Country Link
US (1) US6664268B1 (cs)
EP (1) EP1133497B1 (cs)
JP (2) JP5127094B2 (cs)
KR (1) KR100740950B1 (cs)
CN (1) CN1150193C (cs)
AR (1) AR028467A1 (cs)
AT (1) ATE289606T1 (cs)
AU (1) AU767890B2 (cs)
BR (1) BRPI9915682B8 (cs)
CA (1) CA2351707C (cs)
CZ (1) CZ300012B6 (cs)
DE (2) DE19854355A1 (cs)
DK (1) DK1133497T3 (cs)
ES (1) ES2237186T3 (cs)
HK (1) HK1042705B (cs)
HU (1) HU229071B1 (cs)
IL (2) IL142695A0 (cs)
NO (1) NO318065B1 (cs)
NZ (1) NZ511862A (cs)
PL (1) PL196078B1 (cs)
PT (1) PT1133497E (cs)
RU (1) RU2248355C2 (cs)
SK (1) SK285554B6 (cs)
TR (1) TR200101444T2 (cs)
TW (1) TWI245767B (cs)
UA (1) UA67873C2 (cs)
UY (1) UY25818A (cs)
WO (1) WO2000031076A1 (cs)
ZA (1) ZA200103187B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19854356A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
DE19908448A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
DE102004015981A1 (de) 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
DE102006049520A1 (de) * 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
PE20191462A1 (es) 2017-02-13 2019-10-16 Bayer Animal Health Gmbh Composicion liquida que contiene pradofloxacina

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036099A (en) * 1987-02-02 1991-07-30 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
JP2676521B2 (ja) * 1988-03-22 1997-11-17 北陸製薬株式会社 キノロンカルボン酸化合物ｉ型結晶の製造法
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
JP2832848B2 (ja) * 1989-10-21 1998-12-09 株式会社林原生物化学研究所 結晶２―Ｏ―α―Ｄ―グルコピラノシル―Ｌ―アスコルビン酸とその製造方法並びに用途
BR9509688A (pt) 1994-11-18 1997-09-30 Upjohn Co Composto e composição farmacêutica
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE19633805A1 (de) * 1996-02-23 1997-08-28 Bayer Ag Gegenenenfalls substituierte 8-Cyan-l-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre Derivate
NZ331468A (en) * 1996-02-23 2000-02-28 Bayer Ag Substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4,3.0]-nonan-8-yl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
DE19649681A1 (de) * 1996-11-29 1998-06-04 Basf Ag Verfahren zur Herstellung eines kristallinen Feststoffes aus Glycin-N,N-diessigsäure-Derivaten mit hinreichend geringer Hygroskopizität
DE19854356A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908448A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure

Also Published As

Publication number Publication date
PT1133497E (pt) 2005-07-29
IL142695A (en) 2006-04-10
HUP0104713A2 (hu) 2002-04-29
DK1133497T3 (da) 2005-05-17
SK285554B6 (sk) 2007-03-01
DE19854355A1 (de) 2000-05-31
RU2248355C2 (ru) 2005-03-20
HK1042705B (zh) 2005-03-11
KR100740950B1 (ko) 2007-07-19
KR20010080927A (ko) 2001-08-25
PL196078B1 (pl) 2007-12-31
EP1133497B1 (de) 2005-02-23
JP5127094B2 (ja) 2013-01-23
TWI245767B (en) 2005-12-21
HK1042705A1 (en) 2002-08-23
IL142695A0 (en) 2002-03-10
BR9915682A (pt) 2001-08-14
AR028467A1 (es) 2003-05-14
SK6832001A3 (en) 2001-12-03
AU767890B2 (en) 2003-11-27
CA2351707A1 (en) 2000-06-02
TR200101444T2 (tr) 2002-01-21
UA67873C2 (uk) 2004-07-15
CN1150193C (zh) 2004-05-19
ATE289606T1 (de) 2005-03-15
BRPI9915682B8 (pt) 2021-05-25
NZ511862A (en) 2003-08-29
CN1328556A (zh) 2001-12-26
NO20012461L (no) 2001-05-18
DE59911666D1 (de) 2005-03-31
ES2237186T3 (es) 2005-07-16
HU229071B1 (en) 2013-07-29
WO2000031076A1 (de) 2000-06-02
NO20012461D0 (no) 2001-05-18
NO318065B1 (no) 2005-01-31
ZA200103187B (en) 2002-06-26
PL347785A1 (en) 2002-04-22
UY25818A (es) 2016-06-30
AU1651700A (en) 2000-06-13
CZ300012B6 (cs) 2009-01-14
JP2012236841A (ja) 2012-12-06
JP2002530407A (ja) 2002-09-17
BRPI9915682B1 (pt) 2017-02-21
HUP0104713A3 (en) 2002-12-28
US6664268B1 (en) 2003-12-16
CA2351707C (en) 2011-02-01
EP1133497A1 (de) 2001-09-19

Similar Documents

Publication Publication Date Title
IL119795A0 (en) Crystalline 1-cyclopropyl-7-([S,S]-2,9-diazabicyclo-[4.3.0]non-8-YL) 6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid hydrochloride its preparation and pharmaceutical formulations containing it
IL107221A0 (en) Carboxylic acid derivatives, pharmaceutical compositions containing them and processes for their preparation
HUP9900502A3 (en) 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4,3,0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives, use and medicaments thereof and process producing them
IL107956A0 (en) Carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
CA2283671A1 (en) Salt of naphthyridine carboxylic acid derivative
HUP0000450A3 (en) The use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the preparation of pharmaceutical compositions treating helicobacter pylori infections and associated gastroduodenal diseases
CZ20011857A3 (cs) Krystalická modifikace B kyseliny 8-kyano-1-cyklopropyl-7-(1S,6S-2,8-diazabicyklo-[4,3,0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarboxylové, způsob přípravy a její použití ve farmaceutických přípravcích
EG18484A (en) Process for preparing 1-tertiary-alkyl-substituted naphthyridine and quinoline carboxylic acid antibacterial agents
IL148738A0 (en) Quinoline and naphthyridine carboxylic acid antibacterials
IL126027A0 (en) Novel carboxylic acid derivatives their preparation and use
ZA973096B (en) Novel carboxylic acid derivatives their preparation and use
NZ218880A (en) Pyrido(2,3-b)indole-3-carboxylic acid derivatives and pharmaceutical compositions thereof
CZ20011858A3 (cs) Krystalická modifikace A kyseliny 8-kyano-1-cyklopropyl-7-(1S, 6S-2,8-diazabicyklo-[4,3,0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarboxylové, způsob přípravy a její použití ve farmaceutických přípravcích
AU617974B2 (en) (s)-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid
HUP0200006A2 (en) Crystal modification c of 8-cyano-1-cyclopropyl-7- (1s, 6s-2,8-diazabicyclo - [4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid process for their preparation, pharmaceutical composition comprising thereof and their use
HUS1200019I1 (hu) Adott esetben helyettesített 8-Ciano-1-ciklopropil-7-(2,8-diazabiciklo[4,3,0]nonán-8-il)-6-fluor-1,4-dihidro-4-oxo-3-kinolin-karbonsavak és származékaik, eljárás elõállításukra és ezeket tartalmazó gyógyszerkészítmények
CZ20011753A3 (cs) Semihydrochlorid kyseliny 8-kyano-1-cyklopropyl-7-(1S,6S-2,8-diazabicyklo[4,3,0]nonan-8yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarboxylové, způsob přípravy a jeho použití ve směsích s antibakteriálními účinky
HUP0200053A3 (en) Crystal modification d of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, process for its preparation and pharmaceutical compositions containing the same
IL139102A0 (en) Novel octahydro-6, 10-dioxo-6h-pyridazino/1,2-a//diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds
ZA952759B (en) Process for the preparation of carboxyarenesulfonic acids and their carboxylic acid derivatives
SI0862550T1 (en) Carboxylic acid derivatives, their preparation and their use
HUP9902548A3 (en) Process for preparing quinoline and naphthyridone carboxylic acids
HUT66017A (en) 1-phenyl-1a,2,3,4,6,7,12,12ba-octahydro-pyrimido[1',6',:1,2]pyrido[3,4-b] indole-derivatives and pharmaceutical composition containing them and process for their production

Legal Events

Date Code Title Description
MK4A Patent expired

Effective date: 20191115